Famine versus feast: understanding the metabolism of tumors in vivo.

[1]  D. Sabatini,et al.  SHMT2 drives glioma cell survival in the tumor microenvironment but imposes a dependence on glycine clearance , 2015 .

[2]  M. V. Vander Heiden,et al.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. , 2015, Cancer research.

[3]  A. Harris,et al.  Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress , 2015, Cancer cell.

[4]  Martin E. Fernandez-Zapico,et al.  Faculty Opinions recommendation of Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. , 2015 .

[5]  William J. Israelsen,et al.  Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. , 2014, Molecular cell.

[6]  R. Hammer,et al.  Acetate Dependence of Tumors , 2014, Cell.

[7]  R. Deberardinis,et al.  Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases , 2014, Cell.

[8]  J. Rabinowitz,et al.  Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate , 2014, Cancer & Metabolism.

[9]  E. Cheng,et al.  Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. , 2014, Molecular cell.

[10]  John Kurhanewicz,et al.  Hyperpolarized 13C MR for Molecular Imaging of Prostate Cancer , 2014, The Journal of Nuclear Medicine.

[11]  B. Spiegelman,et al.  Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia , 2014, Nature.

[12]  Zhandong Liu,et al.  Serine catabolism regulates mitochondrial redox control during hypoxia. , 2014, Cancer discovery.

[13]  R. Powers,et al.  Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia , 2014, Cancer & metabolism.

[14]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[15]  K. Vousden,et al.  Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. , 2014, Cell reports.

[16]  Adam M. Feist,et al.  Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. , 2014, Molecular cell.

[17]  Prahlad T. Ram,et al.  Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer , 2014, Molecular systems biology.

[18]  D. Sabatini,et al.  Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides , 2014, Nature.

[19]  Klaus-Peter Adam,et al.  Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth , 2013, Cancer research.

[20]  Mikko I. Kettunen,et al.  Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.

[21]  J. Pippin,et al.  Of rodents and men: species-specific glucose regulation and type 2 diabetes research. , 2014, ALTEX.

[22]  Jean Qiu,et al.  The metabolic demands of cancer cells are coupled to their size and protein synthesis rates , 2013, Cancer & Metabolism.

[23]  Jie Li,et al.  PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells , 2013, Cell.

[24]  Rainer König,et al.  BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1 , 2013, Nature Medicine.

[25]  Thomas M. Wasylenko,et al.  Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells , 2013, Nature Communications.

[26]  E. White,et al.  Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids , 2013, Proceedings of the National Academy of Sciences.

[27]  Christian M. Metallo,et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.

[28]  D. Vitkup,et al.  Heterogeneity of tumor-induced gene expression changes in the human metabolic network , 2013, Nature Biotechnology.

[29]  O. Elemento,et al.  Metabolic Alterations in Lung Cancer–Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor , 2013, Molecular Cancer Research.

[30]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[31]  R. Tomasini,et al.  Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.

[32]  Christian M. Metallo,et al.  Understanding metabolic regulation and its influence on cell physiology. , 2013, Molecular cell.

[33]  Karen Blyth,et al.  Serine starvation induces stress and p53 dependent metabolic remodeling in cancer cells , 2012, Nature.

[34]  J. Wikswo,et al.  Amino acids as metabolic substrates during cardiac ischemia , 2012, Experimental biology and medicine.

[35]  R. Deberardinis,et al.  Metabolism of [U‐13C]glucose in human brain tumors in vivo , 2012, NMR in biomedicine.

[36]  E. Mittra,et al.  Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer , 2012, Clinical Cancer Research.

[37]  R. Deberardinis,et al.  Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. , 2012, Cell metabolism.

[38]  F. Sotgia,et al.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. , 2012, Antioxidants & redox signaling.

[39]  V. Mootha,et al.  Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.

[40]  Wei Liu,et al.  Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC , 2012, Proceedings of the National Academy of Sciences.

[41]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[42]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[43]  Samuel E. Senyo,et al.  Quantitating subcellular metabolism with multi-isotope imaging mass spectrometry , 2011, Nature.

[44]  C. Croce,et al.  Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukemia , 2012, Nature Cell Biology.

[45]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[46]  W. Marston Linehan,et al.  Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.

[47]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[48]  L. Chodosh,et al.  PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine , 2011, The Journal of Nuclear Medicine.

[49]  Jesse M. Platt,et al.  Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.

[50]  G. Mills,et al.  Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.

[51]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[52]  Gregory Stephanopoulos,et al.  Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.

[53]  Gregory Stephanopoulos,et al.  Molecular Systems Biology Peer Review Process File Oncogenic K-ras Decouples Glucose and Glutamine Metabolism to Support Cancer Cell Growth Transaction Report , 2022 .

[54]  Karen H. Vousden,et al.  Metabolic regulation by p53 , 2011, Journal of Molecular Medicine.

[55]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[56]  이연수.  Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .

[57]  Tak W. Mak,et al.  The ER UDPase ENTPD5 Promotes Protein N-Glycosylation, the Warburg Effect, and Proliferation in the PTEN Pathway , 2010, Cell.

[58]  Elizabeth L. Johnson,et al.  Quiescent Fibroblasts Exhibit High Metabolic Activity , 2010, PLoS biology.

[59]  H. Sontheimer,et al.  Hypoxia Increases the Dependence of Glioma Cells on Glutathione* , 2010, The Journal of Biological Chemistry.

[60]  S. Klein,et al.  Metabolic alteration in patients with cancer: Nutritional implications , 2010, Surgery Today.

[61]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[62]  Mariza de Andrade,et al.  Temporal Association of Changes in Fasting Blood Glucose and Body Mass Index With Diagnosis of Pancreatic Cancer , 2009, The American Journal of Gastroenterology.

[63]  H. Pitt,et al.  Obesity potentiates the growth and dissemination of pancreatic cancer. , 2009, Surgery.

[64]  M. Tomita,et al.  Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. , 2009, Cancer research.

[65]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[66]  A. Walch,et al.  Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion , 2009, Proceedings of the National Academy of Sciences.

[67]  S. Ben-Haim,et al.  18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response* , 2008, Journal of Nuclear Medicine.

[68]  F. Ducray,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[69]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[70]  A. Basu,et al.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. , 2009, The Lancet. Oncology.

[71]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[72]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[73]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[74]  Liam A McDonnell,et al.  Imaging mass spectrometry. , 2007, Mass spectrometry reviews.

[75]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[76]  James L Tatum,et al.  Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy , 2006, International journal of radiation biology.

[77]  H. Sontheimer,et al.  Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors , 2005, The Journal of Neuroscience.

[78]  Marta Cascante,et al.  K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts , 2005 .

[79]  J. Esko,et al.  The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.

[80]  O. Warburg.  Über den Stoffwechsel der Carcinomzelle , 1924, Naturwissenschaften.

[81]  P. Pour,et al.  Diabetes mellitus: a risk factor for pancreatic cancer? , 2005, Langenbeck's Archives of Surgery.

[82]  C. Des Rosiers,et al.  Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons. , 2004, American journal of physiology. Heart and circulatory physiology.

[83]  M. Armoni,et al.  The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression , 2004, Cancer Research.

[84]  R. Surtees,et al.  Physiology and pathophysiology of organic acids in cerebrospinal fluid , 1993, Journal of Inherited Metabolic Disease.

[85]  Michael E. Phelps,et al.  PET in clinical oncology , 1988, Cancer and Metastasis Reviews.

[86]  Robert A. Weinberg,et al.  Comparative Biology of Mouse versus Human Cells: Modelling Human Cancer in Mice O P I N I O N , 2022 .

[87]  A. Mero,et al.  Serum amino acid concentrations in aging men and women , 2003, Amino Acids.

[88]  Chi-Lai Ho,et al.  11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[89]  M. Durán,et al.  Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases , 2003, Springer Berlin Heidelberg.

[90]  J. Permert,et al.  The relationship between diabetes and pancreatic cancer , 2003, Molecular Cancer.

[91]  S. Turner,et al.  Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro , 2003, Molecular Cancer.

[92]  M. Cascante,et al.  Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. , 2000, Cancer research.

[93]  D. Wasserman,et al.  Zonation of acetate labeling across the liver: implications for studies of lipogenesis by MIDA. , 1999, The American journal of physiology.

[94]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[95]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[96]  K. Fearon,et al.  Changes in nutritional status associated with unresectable pancreatic cancer. , 1997, British Journal of Cancer.

[97]  J. Everhart,et al.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. , 1995, JAMA.

[98]  A. Harper.  Some concluding comments on emerging aspects of amino acid metabolism. , 1994, The Journal of nutrition.

[99]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[100]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[101]  T. Chuang,et al.  Amino acid concentrations in serum and aqueous humor from subjects with extreme myopia or senile cataract. , 1988, Clinical chemistry.

[102]  J. Norton,et al.  Altered leucine metabolism in noncachectic sarcoma patients. , 1987, Cancer research.

[103]  J. H. Shaw,et al.  Fatty Acid and Glycerol Kinetics in Septic Patients and in Patients with Gastrointestinal Cancer: The Response to Glucose Infusion and Parenteral Feeding , 1987, Annals of surgery.

[104]  J. H. Shaw,et al.  Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion, parenteral feeding, and surgical resection. , 1987, Surgery.

[105]  D. Bar-Sagi,et al.  Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. , 1986, Science.

[106]  R. Miller,et al.  Branched-chain amino acid metabolism. , 1984, Annual review of nutrition.

[107]  Joseph R. Bertino,et al.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.

[108]  M. Weiner,et al.  Measurement of acetate in human blood by gas chromatography: effects of sample preparation, feeding, and various diseases. , 1979, Clinical chemistry.

[109]  P. Paul,et al.  Altered glucose metabolism in metastatic carcinoma. , 1975, Cancer research.

[110]  G F Cahill,et al.  Brain metabolism during fasting. , 1967, The Journal of clinical investigation.

[111]  G E Moore,et al.  Culture of normal human leukocytes. , 1967, JAMA.

[112]  R. Dulbecco,et al.  VIRUS-CELL INTERACTION WITH A TUMOR-PRODUCING VIRUS. , 1960, Proceedings of the National Academy of Sciences of the United States of America.

[113]  H. Eagle,et al.  Amino acid metabolism in mammalian cell cultures. , 1959, Science.

[114]  J. Oncley,et al.  Unbound amino acid concentrations in human blood plasmas. , 1957, The Journal of clinical investigation.

[115]  H. Eagle,et al.  The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. , 1956, The Journal of biological chemistry.

[116]  H. Eagle.  THE SPECIFIC AMINO ACID REQUIREMENTS OF A HUMAN CARCINOMA CELL (STRAIN HELA) IN TISSUE CULTURE , 1955, The Journal of experimental medicine.

[117]  H. Eagle.  The specific amino acid requirements of a mammalian cell (strain L) in tissue culture. , 1955, The Journal of biological chemistry.

[118]  S. Moore,et al.  The free amino acids of human blood plasma. , 1954, The Journal of biological chemistry.

[119]  F. Newell.  Standard Values in Blood , 1952 .